RxDoctor Payments Data

Susan Smith, APRN

Nurse Practitioner · Ponchatoula, LANPI 1154441251

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.2% of the total across 400 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 27.3% of the total. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,415in general payments, 2019–2025

Across 400 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Pfizer$804
  • Amgen$741
  • Regeneron Healthcare Solutions, Inc.$728
  • LEO Pharma Inc.$434
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$7,75792%
  • Education$6578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,415 in reported general payments places this provider in the 95th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Medicare billing

Part B allowed, 2024
$207,129
Medicare patients
444
Services billed
3,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa23$504,646
Dupixent PenDupilumab74$275,800
Cosentyx Sensoready (2 Pens)Secukinumab12$88,241
Humira PenAdalimumab12$80,852
Dupixent SyringeDupilumab15$55,270
Ketoconazole483$10,696
Metronidazole106$5,723
Clobetasol Propionate143$4,740
Doxycycline Hyclate113$3,602
Ammonium Lactate135$3,172
Calcipotriene23$3,083
Tretinoin32$2,725
Triamcinolone Acetonide191$1,898
Ciclopirox27$1,652
Fluorouracil23$1,454

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Ponchatoula

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →